Cross-linked Hyaluronic Acid in Knee Osteoarthritis
Clinical Superiority of Cross-linked Hyaluronic Acid in Knee Osteoarthritis: Sustained Efficacy on Pain and Function
1 other identifier
observational
88
1 country
1
Brief Summary
Knee Osteoarthritis (Knee OA) leads to pain and loss of function, especially in recreational athletes. While hyaluronic acid (HA) injections are a common part of conservative treatment, comparative data on the efficacy of straight-chain (ST-HA) versus cross-linked (CL-HA) formulations remain limited. Therefore, the aim of this study was to compare the 6-month efficacy of a single dose of CL-HA versus two doses of ST-HA regarding pain, stiffness, and joint function in recreational athletes aged 50-70 with Kellgren-Lawrence grade 2-3 Knee OA refractory to pharmacological treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedFirst Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
November 21, 2025
CompletedFebruary 27, 2026
February 1, 2026
4 years
November 17, 2025
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients were comparatively evaluated pre-treatment and at 1, 3, and 6 months post-treatment using the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score.
Minimal value is 0, while maximum value is 96.
Patients were comparatively evaluated pre-treatment and at 1, 3, and 6 months post-treatment
Secondary Outcomes (1)
Patients were comparatively evaluated pre-treatment and at 1, 3, and 6 months post-treatment using the VAS score.
Patients were comparatively evaluated pre-treatment and at 1, 3, and 6 months post-treatment
Interventions
Cross-linked HA was applied as a single dose to the knee via the anterolateral approach.
Straight-bonded HA injection was applied in 2 doses, 4 weeks apart.
Eligibility Criteria
This retrospective observational study was conducted in a multicenter manner and included recreational athletes aged between 50 and 70 years who applied to Medipol Esenler Hospital and Republic of Turkey Ministry of Health Erenköy Physical Therapy and Rehabilitation Hospital due to knee pain and were diagnosed with gonarthrosis between January 2021 and December 2024.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Medipol University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.Prof.
Study Record Dates
First Submitted
November 17, 2025
First Posted
November 21, 2025
Study Start
January 2, 2021
Primary Completion
December 31, 2024
Study Completion
May 31, 2025
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning immediately after publicaiton
- Access Criteria
- I will consider review requests for IPD sharing and how they will be reviewed.
After publication in a journal, I will share all IPD that underlie results in a publication